The role of inflammation in cancer of the esophagus.
![Thumbnail](/xmlui/themes/Mirage2/images/white_rectangle.jpeg)
File Type:
PDFItem Type:
Journal ArticleDate:
2014Access:
openAccessCitation:
O'Sullivan KE, Phelan JJ, O'Hanlon C, Lysaght J, O'Sullivan JN, Reynolds JV., The role of inflammation in cancer of the esophagus., Expert Reviews Gastroenterology Hepatology, 8, 7, 2014, 749 - 760Download Item:
Abstract:
Esophageal adenocarcinoma is the eighth most common malignancy worldwide. The overall prognosis is poor, with 5-year survival ranges of approximately 15-25%, and 30-50% for patients who can be treated with curative intent. There has been a marked increase in incidence of esophageal adenocarcinoma over the last 30 years, with chronic and severe reflux, diet and obesity identified as principal factors fuelling this rise in the West. Esophageal adenocarcinoma is an exemplar model of an inflammation-associated cancer. The key molecular pathways driving tumor development and influencing tumor biology are the subject of considerable research efforts, and is the principal focus of this review. In addition, the diverse range of changes occurring in the local immune response, tissue microenvironment, metabolic profile, intracellular signaling mechanisms and microRNA signatures are discussed, as well as novel targeted therapies.
Sponsor
Grant Number
Irish Cancer Society
CRS120SU
Author's Homepage:
http://people.tcd.ie/jlysaghthttp://people.tcd.ie/osullij4
http://people.tcd.ie/phelanj3
http://people.tcd.ie/reynoljv
Description:
PUBLISHEDType of material:
Journal ArticleCollections
Series/Report no:
Expert Reviews Gastroenterology Hepatology8
7
Availability:
Full text availableKeywords:
CancerSubject (TCD):
Cancer , Immunology, Inflammation & Infection , Biomedical sciencesDOI:
http://dx.doi.org/10.1586/17474124.2014.913478Source URI:
http://www.ncbi.nlm.nih.gov/pubmed/24857183Metadata
Show full item recordLicences: